Jane Street Group, LLC Vanda Pharmaceuticals Inc. Transaction History

Jane Street Group, LLC

$384 Billion
Q1 2025

A detailed history of Jane Street Group, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 61,274 shares of VNDA stock, worth $272,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,274

Previous 13,300 360.71%

Holding current value

$272,056

Previous $61,000 360.66%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$4.31 - $5.13 $162,318 - $193,200	37,661 Added 159.49%	61,274 $281,000
Q4 2024 Feb 14, 2025	SELL	$4.41 - $5.46 $183,799 - $227,561	-41,678 Reduced 63.83%	23,613 $113,000
Q3 2024 Nov 14, 2024	SELL	$4.61 - $6.34 $210,239 - $289,135	-45,605 Reduced 41.12%	65,291 $306,000
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $191,558 - $318,448	48,992 Added 79.14%	110,896 $626,000
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $108,649 - $144,343	-31,311 Reduced 33.59%	61,904 $254,000
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $505,448 - $684,897	-149,541 Reduced 61.6%	93,215 $393,000
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $855,841 - $1.31 Million	199,963 Added 467.28%	242,756 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $252,478 - $297,411	42,793 New	42,793 $282,000
Q3 2021 Nov 16, 2021	BUY	$15.35 - $21.27 $6,262 - $8,678	408 Added 3.95%	10,743 $184,000
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $116,599 - $159,647	-7,422 Reduced 41.8%	10,335 $222,000
Q1 2021 May 18, 2021	SELL	$13.42 - $20.28 $34,207 - $51,693	-2,549 Reduced 12.55%	17,757 $267,000
Q4 2020 Feb 17, 2021	SELL	$9.77 - $13.81 $130,458 - $184,404	-13,353 Reduced 39.67%	20,306 $267,000
Q3 2020 Nov 17, 2020	BUY	$9.32 - $12.02 $313,701 - $404,581	33,659 New	33,659 $326,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $175,605 - $393,355	-23,414 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $289,865 - $409,042	23,414 New	23,414 $384,000
Q2 2018 Aug 15, 2018	SELL	$13.95 - $19.15 $213,183 - $292,650	-15,282 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $214,712 - $308,696	15,282 New	15,282 $258,000

Others Institutions Holding VNDA

# of Institutions

158

Shares Held

44.7M

Call Options Held

64.8K

Put Options Held

562K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $251M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Vanda Pharmaceuticals Inc. Transaction History